Compugen Ltd
CGEN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001119774
In the last 90 days, Compugen Ltd insiders filed 0 open-market purchases and 1 sale; 83 institutions reported holding it in 13F filings for Q2 2026, worth $30.3M in total; ARK Invest is the only superinvestor holding it.
Q2 2022 vs. Q1 2022
How the institutions holding Compugen Ltd changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Of which not filed for Q2 2022 | Q2 2022 | Change |
|---|---|---|---|---|
| Holders | 110 | 2 | 90 | −18 |
| Shares | 42.0M | 187.3K | 37.9M | −3.93M (−9.4%) |
| Value | $135.3M | $603.0K | $70.1M | −$64.6M (−48.0%) |
2 institutions that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Compugen Ltd at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Schonfeld Strategic Advisors LLC | 138,680 | $257.0K | 0.00% |
| Simplex Trading, LLC | 29,106 | $53.0K | 0.00% |
| New York State Common Retirement Fund | 26,957 | $50.0K | 0.00% |
| HighPoint Advisor Group LLC | 15,149 | $32.0K | 0.00% |
| Marshall Wace, LLP | 13,415 | $25.0K | 0.00% |
| Squarepoint Ops LLC | 10,900 | $20.0K | 0.00% |
| Captrust Financial Advisors | 2,225 | $4.00K | 0.00% |
Sold out (25)
Institutions that held Compugen Ltd at the end of Q1 2022 and filed for Q2 2022 without it.
Not filed for Q2 2022 yet (2)
Institutions that held Compugen Ltd at the end of Q1 2022 and haven't filed a 13F for Q2 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Susquehanna Fundamental Investments, LLC | 97,006 | $312.0K |
| Parametric Portfolio Associates LLC | 90,343 | $291.0K |